Thomas C. Victor

5.3k total citations
59 papers, 3.4k citations indexed

About

Thomas C. Victor is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Thomas C. Victor has authored 59 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Infectious Diseases, 49 papers in Epidemiology and 30 papers in Surgery. Recurrent topics in Thomas C. Victor's work include Tuberculosis Research and Epidemiology (51 papers), Mycobacterium research and diagnosis (42 papers) and Infectious Diseases and Tuberculosis (15 papers). Thomas C. Victor is often cited by papers focused on Tuberculosis Research and Epidemiology (51 papers), Mycobacterium research and diagnosis (42 papers) and Infectious Diseases and Tuberculosis (15 papers). Thomas C. Victor collaborates with scholars based in South Africa, United States and India. Thomas C. Victor's co-authors include Robin M. Warren, Paul D. van Helden, Nicolaas C. Gey van Pittius, Nulda Beyers, Elizabeth M. Streicher, Annelies Van Rie, Robert P. Gie, Donald A. Enarson, Madalene Richardson and M. Richardson and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Thomas C. Victor

59 papers receiving 3.3k citations

Peers

Thomas C. Victor
Natalia Kurepina United States
Thomas C. Victor
Citations per year, relative to Thomas C. Victor Thomas C. Victor (= 1×) peers Natalia Kurepina

Countries citing papers authored by Thomas C. Victor

Since Specialization
Citations

This map shows the geographic impact of Thomas C. Victor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Victor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Victor more than expected).

Fields of papers citing papers by Thomas C. Victor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas C. Victor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Victor. The network helps show where Thomas C. Victor may publish in the future.

Co-authorship network of co-authors of Thomas C. Victor

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. Victor. A scholar is included among the top collaborators of Thomas C. Victor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. Victor. Thomas C. Victor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Groessl, Erik J., Théodore G. Ganiats, André Trollip, et al.. (2018). Cost analysis of rapid diagnostics for drug-resistant tuberculosis. BMC Infectious Diseases. 18(1). 102–102. 11 indexed citations
2.
Sirgel, Frederick A., Robin M. Warren, Erik C. Böttger, et al.. (2013). The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks. PLoS ONE. 8(3). e59414–e59414. 53 indexed citations
3.
Müller, Borna, Violet Chihota, Manormoney Pillay, et al.. (2013). Programmatically Selected Multidrug-Resistant Strains Drive the Emergence of Extensively Drug-Resistant Tuberculosis in South Africa. PLoS ONE. 8(8). e70919–e70919. 41 indexed citations
4.
Shanley, Crystal A., et al.. (2013). Characterization of W-Beijing isolates of Mycobacterium tuberculosis from the Western Cape. Vaccine. 31(50). 5934–5939. 8 indexed citations
5.
Sirgel, Frederick A., Robin M. Warren, Elizabeth M. Streicher, et al.. (2012). <b><i>embB</i></b>306 Mutations as Molecular Indicators to Predict Ethambutol Susceptibility in <b><i>Mycobacterium tuberculosis</i></b>. Chemotherapy. 58(5). 358–363. 14 indexed citations
6.
Seddon, James A., Douwe H. Visser, A. Jordaan, et al.. (2012). Impact of Drug Resistance on Clinical Outcome in Children With Tuberculous Meningitis. The Pediatric Infectious Disease Journal. 31(7). 711–716. 33 indexed citations
7.
Seddon, James A., A. Jordaan, Thomas C. Victor, & H. Simon Schaaf. (2012). Discordant Drug Susceptibility For Mycobacterium tuberculosis within Families. The Pediatric Infectious Disease Journal. 31(7). 783–785. 2 indexed citations
8.
Sirgel, Frederick A., Robin M. Warren, Elizabeth M. Streicher, et al.. (2011). Mutations in the rrs A1401G Gene and Phenotypic Resistance to Amikacin and Capreomycin in Mycobacterium tuberculosis. Microbial Drug Resistance. 18(2). 193–197. 56 indexed citations
9.
Louw, Gail, Robin M. Warren, Nicolaas C. Gey van Pittius, et al.. (2011). Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through Efflux. American Journal of Respiratory and Critical Care Medicine. 184(2). 269–276. 129 indexed citations
10.
Chegou, Novel N., Kim G.P. Hoek, Magdalena Kriel, et al.. (2011). Tuberculosis assays: past, present and future. Expert Review of Anti-infective Therapy. 9(4). 457–469. 50 indexed citations
11.
Streicher, Elizabeth M., Borna Müller, Violet Chihota, et al.. (2011). Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Infection Genetics and Evolution. 12(4). 686–694. 62 indexed citations
12.
Ioerger, Thomas R., Xiaohua Chen, Karen M. Dobos, et al.. (2010). The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa. BMC Genomics. 11(1). 670–670. 61 indexed citations
13.
Victor, Thomas C., Rabia Johnson, A. Jordaan, et al.. (2008). Drug susceptibility testing using molecular techniques can enhance tuberculosis diagnosis. The Journal of Infection in Developing Countries. 2(1). 40–5. 9 indexed citations
14.
Johnson, Rabia, et al.. (2006). Drug Resistance inMycobacterium tuberculosis. Current Issues in Molecular Biology. 8(2). 97–111. 172 indexed citations
15.
Rie, Annelies Van, Thomas C. Victor, Madalene Richardson, et al.. (2005). Reinfection and Mixed Infection Cause Changing Mycobacterium tuberculosis Drug-Resistance Patterns. American Journal of Respiratory and Critical Care Medicine. 172(5). 636–642. 149 indexed citations
16.
Warren, Robin M., Thomas C. Victor, Elizabeth M. Streicher, et al.. (2004). Patients with Active Tuberculosis often Have Different Strains in the Same Sputum Specimen. American Journal of Respiratory and Critical Care Medicine. 169(5). 610–614. 224 indexed citations
17.
Hesseling, Anneke C., H. Simon Schaaf, Thomas C. Victor, et al.. (2004). Resistant Mycobacterium bovis Bacillus Calmette-Gu??rin Disease : Implications for Management of Bacillus Calmette-Gu??rin Disease in Human Immunodeficiency Virus-Infected Children. The Pediatric Infectious Disease Journal. 23(5). 476–479. 33 indexed citations
18.
Werely, Cedric J., et al.. (2003). Allele Frequencies for Glutathione S-Transferase and N-Acetyltransferase 2 Differ in African Population Groups and May Be Associated With Oesophageal Cancer or Tuberculosis Incidence. Clinical Chemistry and Laboratory Medicine (CCLM). 41(4). 600–5. 36 indexed citations
19.
Victor, Thomas C., et al.. (2003). Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa. Cancer Genetics and Cytogenetics. 140(1). 23–30. 39 indexed citations
20.
Victor, Thomas C., Hyeyoung Lee, Sang-Nae Cho, et al.. (2002). Molecular Detection of Early Appearance of Drug Resistance during Mycobacterium tuberculosis Infection. Clinical Chemistry and Laboratory Medicine (CCLM). 40(9). 876–81. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026